• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

OATL 2016: Programme

OATL Logo

Chairpersons:
Dr Thomas Lynch, Professor Tariq Enver, Professor Daniel Hochhauser

Please note that timings are provisional and subject to change.
Speaker Conflict of Interest forms are here
Confirmation of accreditation is here
Thursday evening

18:30
Welcome to the event
The Chairpersons

18:35
The Lancet Haematology Lecture:- introduced by Dr Lan-Lan Smith – Editor of the Lancet Haematology
Childhood ALL in the UK: Treatment at the Limits
Professor Ajay Vora
Consultant Paediatric Haematologist, Sheffield Children’s Hospital, Sheffield, United Kingdom

19:20
High-precision radiotherapy and the integration of modern imaging techniques
Prof. Dr. med. Stephanie E. Combs
Head of the Department of Radiation Oncology, The Technical University of Munich, Munich, Germany

Friday

08:30
Early detection and treatment of cancer of the oesophagus
Professor Rebecca Fitzgerald
Honorary Consultant Physician, Addenbrooke’s NHS Trust; Director of Studies for Medical Sciences, Trinity College, Cambridge, University of Cambridge, Cambridge, United Kingdom

09:15
T-cell mediated immunotherapies for Cancer
Professor Robert Hawkins
Director of Medical Oncology at the University of Manchester and Christie Hospital, Manchester, United Kingdom

Break

10:30
Cancer immunotherapy affecting patients with unresectable stage III or stage IV malignant melanoma
Dr Mario Sznol
Professor of Medicine (Medical Oncology); Co-Director, Yale SPORE in Skin Cancer, Yale School of Medicine, New Haven, CT., USA

11:15
Immunotherapy in bladder cancer: research at the limits
Dr Daniel P. Petrylak
Professor Medical of Oncology & Urology; Professor; Co-Director, Signal Transduction Research Program, Prostate and Urologic Cancer Program, Smilow Cancer Hospital at Yale – New Haven, USA

Lunch

13:00
The Lancet Oncology Lecture:- introduced by Dr Cassandra Coburn – Deputy Editor of the Lancet Oncology
Targeted therapy in Breast Cancer matched to individuals’ genomic alterations
Professor Fabrice Andre
Director, Translational Research Laboratory, Institut Gustave Roussy, Villejuif, France

13:45
Immunotherapy for the treatment of triple-negative breast cancer
Dr Rita Nanda
Associate Director, Breast Medical Oncology, the University of Chicago, MA., USA

Break

15:00
Image guided therapy of Hepatomas
Dr Jeff Geschwind
Chair of the Department of Radiology and Biomedical Imaging & Chief of Radiology and Biomedical Imaging at Yale School of Medicine and Yale-New Haven Hospital, New Haven, CT USA

15:45
Novel Personalised Therapeutic Strategies in Pancreatic Cancer
Professor Andrew Biankin
Regius Chair of Surgery & Director of the Translational Research Centre, Institute of Cancer Sciences, University of Glasgow, Bearsden, United Kingdom

Saturday

09:00
The cellular complexity of nerve regeneration- implications for nerve repair and tumourigenesis
Professor Alison Lloyd
Professor of cell biology, MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom

09:45
Phase 1 trial design
Professor Ruth Plummer
Clinical Professor of Experimental Cancer Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom

Break

11:00
Extracting clues for developing new EGFR inhibitory approaches in cancer
Dr Mark Lemmon
Professor of Pharmacology; Co-director, Cancer Biology Institute, Yale School of Medicine, New Haven, CT., USA

11:45
Using functional genomics to identify genes that modify the tumor cell response to therapy
Professor Alan Ashworth
Director of the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA

Lunch

13:30
Isoforms of PI 3-kinase in cancer
Professor Bart Vanhaesebroeck
Professor of Cell Signalling, Research Department of Oncology, UCL Cancer Institute, London, United Kingdom, UK

14:15
Alternating electric fields and other advances for treatment of glioma
Professor Roger Stupp
Chair & Director, Department of Oncology, University Hospital Zurich, Zurich, Switzerland

Oncology at the Limits is supported by educational grants from the Pharmaceutical Industry
A list of 2016 supporters is at http://www.atthelimits.org/supporters-2016/

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info